Biography: Yasir Abu-Omar, MD
- Surgical Director, Advanced Heart Failure and Transplant Center, Harrington Heart and Vascular Institute, University Hospitals
- Director, Cardiothoracic Transplantation and Mechanical Circulatory Support, Cardiac Surgery, UH Cleveland Medical Center
- Clinical Professor, CWRU School of Medicine
Residency | Cardiothoracic Surgery
Cardiothoracic Surgery - Royal Papworth Hospital (2007 - 2012)
University Of Aberdeen School Of Medicine (1997)
AboutView Provider’s Blog
Yasir Abu-Omar, MD, DPhil, is the Surgical Director of the Advanced Heart Failure & Transplant Center, and the Russ and Connie Lincoln Chair in Cardiovascular Innovation at University Hospitals Harrington Heart & Vascular Institute. He is also a Clinical Professor of Surgery at Case Western Reserve University School of Medicine.
Dr. Abu-Omar earned his medical degree from the University of Aberdeen School of Medicine before earning his Doctor of Philosophy from the University of Oxford. He completed a residency in cardiothoracic surgery at Royal Papworth Hospital and is a fellow of the Royal College of Surgeons.
Dr. Abu-Omar spent more than a decade as a cardiothoracic and transplant surgeon in England before coming to the United States to join the surgical team at University Hospitals Harrington Heart & Vascular Institute. His special interests include complex heart valve surgery, minimally invasive heart valve surgery, aortic valve surgery, coronary artery bypass operations and surgery for heart failure. Dr. Abu-Omar has particular skill in performing ventricular assist device (VAD) implantations, Bi-VAD implants, heart and lung transplantations, as well as surgery for hypertrophic cardiomyopathy and pulmonary endarterectomy in patients with chronic pulmonary artery occlusions.
Beyond his surgical practice, Dr. Abu-Omar is active in professional societies and research activities. He has a passion for teaching and training other physicians, having received numerous invitations to lecture on various topics related to cardiothoracic surgery in national and international forums. He has led several prestigious clinical trials as principal investigator and authored over 100 peer-reviewed publications and abstracts.
Related Blog Articles
Swift mobilization of the extracorporeal cardiopulmonary resuscitation (ECPR) team at University Hospitals saved the life of a cardiac arrest patient.
University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.
UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.
View UH’s policy (PDF) on practitioner-industry relationships.
As of December 31, 2016, Yasir Abu-Omar did not disclose any Outside Relationships with Industry.